Manage settings
MENU
About this site
In het Nederlands
Home
Researchers
Projects
Organisations
Outputs & Impact
Infrastructure
Contact
Research Explorer
Your browser does not support JavaScript or JavaScript is not enabled. Without JavaScript some functions of this webapplication may be disabled or cause error messages. To enable JavaScript, please consult the manual of your browser or contact your system administrator.
Researcher
Jan Van Meerbeeck
Profile
Projects
Publications & Research Data
Activities
Awards & Distinctions
Patents
231
Results
2025
Haptoglobin phenotype : a germline risk factor for malignant pleural mesothelioma? A case-control study
Kevin Lamote
Sigurd Delanghe
Marijn Speeckaert
Jan Van Meerbeeck
Joris Delanghe
A1
Journal Article
in
CLINICA CHIMICA ACTA
2025
2024
A randomised phase II study of extended pleurectomy/decortication preceded or followed by chemotherapy in patients with early-stage pleural mesothelioma : EORTC 1205
Jo Raskin
Veerle Surmont
Alexander P.W.M. Maat
Maha Yahia
Sjaak A. Burgers
Yassin Pretzenbacher
Frederic De Ryck
Robin Cornelissen
Houke M. Klomp
Ana Oliveira
et al.
A1
Journal Article
in
EUROPEAN RESPIRATORY JOURNAL
2024
2022
Headspace volatile organic compound profiling of pleural mesothelioma and lung cancer cell lines as translational bridge for breath research
Eline Janssens
Zoë Mol
Lore Vandermeersch
Sabrina Lagniau
Karim Vermaelen
Jan Van Meerbeeck
Christophe Walgraeve
Elly Marcq
Kevin Lamote
A1
Journal Article
in
FRONTIERS IN ONCOLOGY
2022
2021
Coping strategy influences quality of life in patients with advanced lung cancer by mediating mood
Mick van de Wiel
Sofie Derijcke
Daniella Galdermans
Marc Daenen
Veerle Surmont
Els De Droogh
Anneke Lefebure
Erika Saenen
Elke Vandenbroucke
Ann-Marie Morel
et al.
A1
Journal Article
in
CLINICAL LUNG CANCER
2021
Lung cancer in Belgium
Sebahat Ocak
Kurt Tournoy
Thierry Berghmans
Ingel Demedts
Rodolphe Durieux
Annelies Janssens
Luigi Moretti
Kristiaan Nackaerts
Thierry Pieters
Veerle Surmont
et al.
Editorial material
2021
2020
A literature review of the potential diagnostic biomarkers of head and neck neoplasms
Heleen Konings
Sofie Stappers
Margot Geens
Benedicte Y. De Winter
Kevin Lamote
Jan Van Meerbeeck
Pol Specenier
Olivier M. Vanderveken
Kristien J. Ledeganck
A1
Journal Article
in
FRONTIERS IN ONCOLOGY
2020
The scent of COVID-19 : viral (semi-)volatiles as fast diagnostic biomarkers?
Kevin Lamote
Eline Janssens
Eline Schillebeeckx
Therese S. Lapperre
Benedicte Y. De Winter
Jan Van Meerbeeck
A1
Journal Article
in
JOURNAL OF BREATH RESEARCH
2020
Volatile organic compounds in human matrices as lung cancer biomarkers : a systematic review
Eline Janssens
Jan Van Meerbeeck
Kevin Lamote
A1
Journal Article
in
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
2020
2019
The electronic nose : emerging biomarkers in lung cancer diagnostics
WH van Geffen
Kevin Lamote
A Costantini
Lizza E.L. Hendriks
NM Rahman
TG Blum
Jan Van Meerbeeck
A2
Journal Article
in
BREATHE
2019
2018
Breath analysis as a diagnostic and screening tool for malignant pleural mesothelioma : a systematic review
Lisa Brusselmans
Lieselot Arnouts
Charissa Millevert
Joyce Vandersnickt
Jan Van Meerbeeck
Kevin Lamote
A1
Journal Article
in
TRANSLATIONAL LUNG CANCER RESEARCH
2018
Breath analysis by ion mobility spectrometry allows to discriminate COPD from lung cancer patients
Eline Janssens
Kevin Lamote
Jan Van Meerbeeck
Lisa Brusselmans
C3
Conference
2018
Monocyte-derived dendritic cells in lung cancer : from partner in crime to therapeutic option
Elisabeth Brabants
Karim Vermaelen
Jan Van Meerbeeck
Dissertation
2018
2017
Biomarkers for early diagnosis of malignant mesothelioma : do we need another moonshot?
Sabrina Lagniau
Kevin Lamote
Jan Van Meerbeeck
Karim Vermaelen
A1
Journal Article
in
ONCOTARGET
2017
Breath analysis by gas chromatography-mass spectrometry and electronic nose to screen for pleural mesothelioma : a cross-sectional case-control study
Kevin Lamote
Paul Brinkman
Lore Vandermeersch
Matthijs Vynck
Peter J Sterk
Herman Van Langenhove
Olivier Thas
Joris Van Cleemput
Kristiaan Nackaerts
Jan Van Meerbeeck
A1
Journal Article
in
ONCOTARGET
2017
Breath analysis by gas chromatography-mass spectrometry can be used to screen for pleural mesothelioma
Kevin Lamote
Lore Vandermeersch
Herman Van Langenhove
Joris Van Cleemput
Kristiaan Nackaerts
Jan Van Meerbeeck
C3
Conference
2017
Concurrent once-daily versus twice-daily chemoradiotherapy in patients with limited-stage small-cell lung cancer (CONVERT) : an open-label, phase 3, randomised, superiority trial
Corinne Faivre-Finn
Michael Snee
Linda Ashcroft
Wiebke Appel
Fabrice Barlesi
Adityanarayan Bhatnagar
Andrea Bezjak
Felipe Cardenal
Pierre Fournel
Susan Harden
et al.
A1
Journal Article
in
LANCET ONCOLOGY
2017
Exhaled breath analysis allows exclusive screening for malignant pleural mesothelioma
Kevin Lamote
Matthijs Vynck
Olivier Thas
Joris Van Cleemput
Kristiaan Nackaerts
Jan Van Meerbeeck
C3
Conference
2017
Exhaled breath to screen for malignant pleural mesothelioma : a validation study
Kevin Lamote
Matthijs Vynck
Olivier Thas
Joris Van Cleemput
Kristiaan Nackaerts
Jan Van Meerbeeck
A1
Journal Article
in
EUROPEAN RESPIRATORY JOURNAL
2017
Volatile organic compounds and malignant pleural mesothelioma : simply breathtaking?
Kevin Lamote
Jan Van Meerbeeck
Dissertation
2017
2016
Breath analysis by gas chromatography-mass spectrometry can be used to screen for pleural mesothelioma
Kevin Lamote
Joris Van Cleemput
Kristiaan Nackaerts
Lore Vandermeersch
Herman Van Langenhove
Jan Van Meerbeeck
C3
Conference
2016
Detection of malignant pleural mesothelioma in exhaled breath by multicapillary column/ion mobility spectrometry (MCC/IMS)
Kevin Lamote
Matthijs Vynck
Joris Van Cleemput
Olivier Thas
Kristiaan Nackaerts
Jan Van Meerbeeck
A1
Journal Article
in
JOURNAL OF BREATH RESEARCH
2016
Money rules the world
Paul Baas
Jan Van Meerbeeck
Editorial material
2016
Prospective evaluation of first-line erlotinib in advanced non-small cell lung cancer (NSCLC) carrying an activating EGFR mutation : a multicenter academic phase II study in Caucasian patients (FIELT)
Jacques De Grève
Jan Van Meerbeeck
Johan F Vansteenkiste
Lore Decoster
Anne-Pascale Meert
Peter Vuylsteke
Christian Focan
Jean-Luc Canon
Yves Humblet
Guy Berchem
et al.
A1
Journal Article
in
PLOS ONE
2016
Sunitinib (SU11248) in patients with chemo naive extensive small cell lung cancer or who have a 'chemosensitive' relapse: a single-arm phase II study (EORTC-08061)
Fatma Abdelraouf
Egbert Smit
Baktiar Hasan
Jessica Menis
Sanjay Popat
Jan Van Meerbeeck
Veerle Surmont
Paul Baas
Mary O'Brien
A1
Journal Article
in
EUROPEAN JOURNAL OF CANCER
2016
The International Association for the Study of Lung Cancer Lung Cancer Staging Project: proposals for the revision of the clinical and pathologic staging of small cell lung cancer in the forthcoming eighth edition of the TNM Classification for Lung Cancer
Andrew G Nicholson
Kari Chansky
John Crowley
Ricardo Beyruti
Kaoru Kubota
Andrew Turrisi
Wilfried EE Eberhardt
Jan Van Meerbeeck
Ramón Rami-Porta
A1
Journal Article
in
JOURNAL OF THORACIC ONCOLOGY
2016
VOC analysis in headspace air of mesothelioma and lung cancer cell lines: a comparative literature study
Sabrina Lagniau
Kevin Lamote
Karim Vermaelen
Jan Van Meerbeeck
C3
Conference
2016
2015
Adjuvant chemotherapy for resected early-stage non-small cell lung cancer
S Burdett
JP Pignon
J Tierney
H Triboded
L Stewart
C Le Pechoux
A Aupérin
T Le Chevalier
RJ Stephens
R Arriagada
et al.
A1
Journal Article
in
COCHRANE DATABASE OF SYSTEMATIC REVIEWS
2015
Breath analysis by ion mobility spectrometry allows discrimination of pleural mesothelioma patients from controls
Kevin Lamote
Matthijs Vynck
Joris Van Cleemput
Olivier Thas
Kristiaan Nackaerts
Jan Van Meerbeeck
C3
Conference
2015
Breathomics : analyse respiratoire non invasive pour le diagnostic du cancer pulmonaire
Kevin Lamote
Jan Van Meerbeeck
Other
2015
Breathomics: niet-invasieve ademanalyse voor longkanker diagnose
Kevin Lamote
Jan Van Meerbeeck
A2
Journal Article
in
ONCO HEMATO
2015
Cons: long-term CT-scan follow-up is not the standard of care in patients curatively treated for an early stage non-small cell lung cancer
Jan Van Meerbeeck
Halil Sirimsi
Editorial material
2015
Estimation of post-operative forced expiratory volume by functional respiratory imaging
Annelies Janssens
Wim Vos
Cedric Van Holsbeke
Paul Van Schil
Ellie Oostveen
Jan De Backer
Laurens Carps
Annemie Snoeckx
Wilfried De Backer
Jan Van Meerbeeck
A1
Journal Article
in
EUROPEAN RESPIRATORY JOURNAL
2015
Exhaled breath as diagnostic tool for malignant pleural mesothelioma
Kevin Lamote
Filip Lardon
Joris Van Cleemput
Kristiaan Nackaerts
Olivier Thas
Jan Van Meerbeeck
C3
Conference
2015
Implicit attitudes towards smoking predict long-term relapse in abstinent smokers
Adriaan Spruyt
Valentine Lemaigre
Bihiyga Salhi
Dinska Van Gucht
Helen Tibboel
Bram Van Bockstaele
Jan De Houwer
Jan Van Meerbeeck
Kristiaan Nackaerts
A1
Journal Article
in
PSYCHOPHARMACOLOGY
2015
Integrating early palliative care (EPC) in the management of lung cancer: the role of the thoracic oncologist
A Janssens
L Teugels
S Kohl
T Michielsen
Jan Van Meerbeeck
A1
Journal Article
in
LUNG CANCER
2015
Mesothelioma treatment: are we on target : a review
Birgitta I Hiddinga
Christian Rolfo
Jan Van Meerbeeck
A1
Journal Article
in
JOURNAL OF ADVANCED RESEARCH
2015
New aspects in pulmonary rehabilitation
Bihiyga Salhi
Eric Derom
Jan Van Meerbeeck
Dissertation
2015
Poliklinische rookstopinterventie bij rokers met comorbiditeiten
Barbara Sonneville
Bihiyga Salhi
GINA VAN DAMME
Eric Derom
Jan Van Meerbeeck
A2
Journal Article
in
TIJDSCHRIFT VOOR GENEESKUNDE
2015
Rebuttal from dr. van Meerbeeck
Jan Van Meerbeeck
Editorial material
2015
Rehabilitation in patients with radically treated respiratory cancer : a randomised controlled trial comparing two training modalities
Bihiyga Salhi
Christel Haenebalcke
Silvia Perez-Bogerd
Mai D Nguyen
Vincent Ninane
Thomas Malfait
Karim Vermaelen
Veerle Surmont
GEORGES VAN MAELE
Roos Colman
et al.
A1
Journal Article
in
LUNG CANCER
2015
Revalidatie voor longkankerpatiënten
Bihiyga Salhi
Jan Van Meerbeeck
Eric Derom
A2
Journal Article
in
ONCO HEMATO
2015
Second line therapy in malignant pleural mesothelioma: a systematic review
Wieneke A Buikhuisen
Birgitta I Hiddingab
Paul Baas
Jan Van Meerbeeck
A1
Journal Article
in
LUNG CANCER
2015
Small-cell lung cancer: local therapy for a systemic disease?
Jan Van Meerbeeck
David Ball
Editorial material
2015
Targeting immune checkpoints : new opportunity for mesothelioma treatment?
Elly Marcq
Patrick Pauwels
Jan Van Meerbeeck
Evelien LJ Smits
A1
Journal Article
in
CANCER TREATMENT REVIEWS
2015
The MDM2-inhibitor Nutlin-3 synergizes with cisplatin to induce p53 dependent tumor cell apoptosis in non-small cell lung cancer
Christophe Deben
An Wouters
Ken Op de Beeck
Jolien van den Bossche
Julie Jacobs
Karen Zwaenepoel
Marc Peeters
Jan Van Meerbeeck
Filip Lardon
Christian Rolfo
et al.
A1
Journal Article
in
ONCOTARGET
2015
Treatment patterns and survival analysis in 9014 patients with malignant pleural mesothelioma from Belgium, the Netherlands and England
RA Damhuis
A Khakwani
H De Schutter
AL Rich
JA Burgers
Jan Van Meerbeeck
A1
Journal Article
in
LUNG CANCER
2015
Use of the lung cancer-specific quality of life questionnaire EORTC QLQ-LC13 in clinical trials: a systematic review of the literature 20 years after its development
Michael Koller
Sophie Warncke
Marianne J Hjermstad
Juan Arraras
Cecilia Pompili
Amelie Harle
Colin D Johnson
Wei-Chu Chie
Christian Schulz
Florian Zeman
et al.
A1
Journal Article
in
CANCER
2015
Volatile organic compounds increase the likelihood of detecting malignant pleural mesothelioma
Kevin Lamote
Matthijs Vynck
Joris Van Cleemput
Olivier Thas
Kristiaan Nackaerts
Jan Van Meerbeeck
C3
Conference
2015
What can platinum offer yet in the treatment of PS2 NSCLC patients?: a systematic review and meta-analysis
Giuseppe Bronte
Christian Rolfo
Francesco Passiglia
Sergio Rizzo
Ignacio Gil-Bazo
Eugenio Fiorentino
Massimo Cajozzo
Jan Van Meerbeeck
Cosimo Lequaglie
Daniele Santini
et al.
A1
Journal Article
in
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
2015
2014
A breath test for diagnosing malignant pleural mesothelioma
Kevin Lamote
Birgitta Hiddinga
Joris Van Cleemput
Kristiaan Nackaerts
Olivier Thas
Jan Van Meerbeeck
C3
Conference
2014
A rare cause of haemoptysis
Sarah Loof
MD van Borsel
Guy Joos
Jan Van Meerbeeck
A1
Journal Article
in
ACTA CLINICA BELGICA
2014
Are erlotinib and gefitinib interchangeable, opposite or complementary for non-small cell lung cancer treatment?: biological, pharmacological and clinical aspects
Giuseppe Bronte
Christian Rolfo
Elisa Giovannetti
Giuseppe Cicero
Patrick Pauwels
Francesco Passiglia
Marta Castiglia
Sergio Rizzo
Francesca Lo Vullo
Eugenio Fiorentino
et al.
A1
Journal Article
in
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
2014
Functional respiratory imaging to predict post-operative FEV1 after lobectomy/pneumonectomy
Wim Vos
Annelies Janssens
Cedric Van Holsbeke
Glenn Leemans
Jan De Backer
Wilfried De Backer
Paul Van Schil
Jan Van Meerbeeck
C3
Conference
2014
Progression free survival rate at 9 and 18 weeks predict overall survival in patients with malignant pleural mesothelioma: an individual patient pooled analysis of 10 European Organisation for Research and Treatment of Cancer Lung Cancer Group studies and an independent study validation
Hasan Baktiar
Laurent Greillier
Athanasios Pallis
Jessica Menis
Rabab Gaafar
Richard Sylvester
Dean A Fennell
Paul Baas
Veerle Surmont
Jan Van Meerbeeck
et al.
A1
Journal Article
in
EUROPEAN JOURNAL OF CANCER
2014
Strengths, weaknesses, and opportunities of diagnostic breathomics in pleural mesothelioma: a hypothesis
Kevin Lamote
Kristiaan Nackaerts
Jan Van Meerbeeck
A1
Journal Article
in
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
2014
Supplementary prognostic variables for pleural mesothelioma : a report from the IASLC Staging Committee
Harvey I Pass
Dorothy Giroux
Catherine Kennedy
Enrico Ruffini
Ayten K Cangir
David Rice
Hisao Asamura
David Waller
John Edwards
Walter Weder
et al.
A1
Journal Article
in
JOURNAL OF THORACIC ONCOLOGY
2014
Survival outcomes in patients with advanced non-small cell lung cancer treated with erlotinib: expanded access programme data from Belgium (the TRUST study)
Jan Van Meerbeeck
D Galdermans
F Bustin
L De Vos
I Lechat
I Abraham
A1
Journal Article
in
EUROPEAN JOURNAL OF CANCER CARE
2014
The effect of radical treatment and rehabilitation on muscle mass and strength: a randomized trial in stages I-III lung cancer patients
Bihiyga Salhi
Wouter Huysse
GEORGES VAN MAELE
Veerle Surmont
Eric Derom
Jan Van Meerbeeck
A1
Journal Article
in
LUNG CANCER
2014
Volatile organic compounds as an early diagnostic tool for malignant pleural mesothelioma
Kevin Lamote
Joris Van Cleemput
Kristiaan Nackaerts
Jan Van Meerbeeck
C3
Conference
2014
2013
A randomized phase 2 study of paclitaxel and carboplatin with or without conatumumab for first-line treatment of advanced non-small-cell lung cancer
Luis Paz-Ares
Beatrix Bálint
Richard H de Boer
Jan Van Meerbeeck
Rafal Wierzbicki
Paul De Souza
Francesco Galimi
Vincent Haddad
Tony Sabin
Yong-Jiang Hei
et al.
A1
Journal Article
in
JOURNAL OF THORACIC ONCOLOGY
2013
BIBF 1120/nintedanib: a new triple angiokinase inhibitor-directed therapy in patients with non-small cell lung cancer
Christian Rolfo
Luis E Raez
Giuseppe Bronte
Edgardo S Santos
Kostantinos Papadimitriou
Lucio Buffoni
Jan Van Meerbeeck
Antonio Russo
A1
Journal Article
in
EXPERT OPINION ON INVESTIGATIONAL DRUGS
2013
End of life care in lung cancer patients: not at life’s end?
Annelies Janssens
Liesbeth Teugels
Jan Van Meerbeeck
Editorial material
2013
Fibulin-3 as a biomarker for pleural mesothelioma
Kevin Lamote
Paul Baas
Jan Van Meerbeeck
A1
Journal Article
in
NEW ENGLAND JOURNAL OF MEDICINE
2013
Is postoperative FEV1 (poFEV1) more accurately estimated by functional respiratory imaging (FRI) than by conventional methods?
Annelies Janssens
Cedric Van Holsbeke
Wim Vos
Paul Van Schil
Elly Oostveen
Laurens Carp
Wilfried De Backer
Jan Van Meerbeeck
C3
Conference
2013
Management of malignant pleural mesothelioma: have we made any progress?
BIRGITTA HIDDINGA
Veerle Surmont
Jan Van Meerbeeck
A1
Journal Article
in
PANMINERVA MEDICA
2013
Outcome and prognostic factors of bronchopulmonary neuroendocrine tumors (BNETS): a single institutional series
Charlotte Verroken
BIRGITTA HIDDINGA
Liesbeth Ferdinande
Veerle Surmont
Frederic De Ryck
Karim Vermaelen
Karen Geboes
Jan Van Meerbeeck
C3
Conference
2013
Phase II study of first-line bortezomib and cisplatin in malignant pleural mesothelioma and prospective validation of progression free survival rate as a primary end-point for mesothelioma clinical trials (European Organisation for Research and Treatment of Cancer 08052)
Mary ER O'Brien
Rabab M Gaafar
Sanjay Popat
Francesco Grossi
Allan Price
Denis C Talbot
Tanja Cufer
Christian Ottensmeier
Sarah Danson
Athanasios Pallis
et al.
A1
Journal Article
in
EUROPEAN JOURNAL OF CANCER
2013
Resistance training in patients with radically treated respiratory cancer: a prospective randomized multi-center study (REINFORCE)
Jan Van Meerbeeck
Bihiyga Salhi
C Haenebalcke
S Perez-Bogerd
MD Nguyen
Thomas Malfait
Karim Vermaelen
Veerle Surmont
GEORGES VAN MAELE
Eric Derom
C3
Conference
2013
Resistance training in patients with radically treated respiratory cancer: mature results of a multi-centre randomised phase 3 trial (REINFORCE)
Jan Van Meerbeeck
Bihiyga Salhi
Christel Haenebalcke
Sylvia Perez-Bogerd
May D Nguyen
Thomas Malfait
Karim Vermaelen
Veerle Surmont
GEORGES VAN MAELE
Roos Colman
et al.
C3
Conference
2013
Revalidatie van kankergerelateerde chronische vermoeidheid: achtergrond
Bihiyga Salhi
BARBARA VAN RUYMBEKE
Jan Bourgois
Jan Van Meerbeeck
Eric Derom
Bookchapter
in
Chronische vermoeidheid : een praktische handleiding voor de revalidatie van kanker, MS, fibromyalgie en CVS
2013
Revalidatie van kankergerelateerde chronische vermoeidheid: assessment
Bihiyga Salhi
BARBARA VAN RUYMBEKE
Jan Bourgois
Jan Van Meerbeeck
Eric Derom
Bookchapter
in
Chronische vermoeidheid : een praktische handleiding voor de revalidatie van kanker, MS, fibromyalgie en CVS
2013
Revalidatie van kankergerelateerde chronische vermoeidheid: casuïstiek
Bihiyga Salhi
BARBARA VAN RUYMBEKE
Jan Bourgois
Jan Van Meerbeeck
Eric Derom
Bookchapter
in
Chronische vermoeidheid : een praktische handleiding voor de revalidatie van kanker, MS, fibromyalgie en CVS
2013
Revalidatie van kankergerelateerde chronische vermoeidheid: revalidatie
Bihiyga Salhi
BARBARA VAN RUYMBEKE
Jan Bourgois
Jan Van Meerbeeck
Eric Derom
Bookchapter
in
Chronische vermoeidheid : een praktische handleiding voor de revalidatie van kanker, MS, fibromyalgie en CVS
2013
Screening tools for a high risk population: can we screen for early mesothelioma?
Jan Van Meerbeeck
Kevin Lamote
C3
Conference
2013
Second opinion for thoracic cancer and its impact on diagnosis and treatment strategy: a single institutional series
Thomas Malfait
Veerle Surmont
Birgitta I Hiddinga
Karim Vermaelen
Jan Van Meerbeeck
C3
Conference
2013
Spirometric reference values for an East-African population
Sanctus Musafiri
Jan Van Meerbeeck
Laurent Musango
Eric Derom
Guy Brusselle
Guy Joos
Claver Rutayisire
guy joos
A1
Journal Article
in
RESPIRATION
2013
Surgery in mesothelioma: where do we go after MARS?
Birgitta I Hiddinga
Jan Van Meerbeeck
A1
Journal Article
in
JOURNAL OF THORACIC ONCOLOGY
2013
Surgery or radiotherapy for early-stage lung cancer: a potential comparison bias
Paul E Van Schil
Jan Van Meerbeeck
A1
Journal Article
in
LANCET ONCOLOGY
2013
The seventh tumour–node–metastasis staging system for lung cancer: sequel or prequel?
Jan Van Meerbeeck
Annelies Janssens
A2
Journal Article
in
EUROPEAN JOURNAL OF CANCER SUPPLEMENTS
2013
Volatile organic compounds as an early diagnostic tool for malignant pleural mesothelioma
Kevin Lamote
Joris Van Cleemput
Kristiaan Nackaerts
Jan Van Meerbeeck
C3
Conference
2013
Volatile organic compounds as diagnostic tool for malignant pleural mesothelioma
Kevin Lamote
Joris Van Cleemput
Kristiaan Nackaerts
Jan Van Meerbeeck
C3
Conference
2013
Volatile organic compounds in the breath of cystic fibrosis patients: a pilot phase
Kevin Lamote
Guy Joos
Jan Van Meerbeeck
C3
Conference
2013
2012
Activating EGFR mutations in patients with non small cell lung cancer: prevalence and predictors in a caucasian series
Thomas Malfait
Liesbeth Ferdinande
Kurt Tournoy
D Galdermans
Marleen Praet
Veerle Surmont
Ramses Forsyth
Karim Vermaelen
Jan Van Meerbeeck
C3
Conference
2012
Are EUS-FNA and EBUS-TBNA specimens reliable for subtyping non-small cell lung cancer?
Kurt Tournoy
MARILYN CARPRIEAUX
Ellen Deschepper
Jan Van Meerbeeck
Marleen Praet
A1
Journal Article
in
LUNG CANCER
2012
Effect of radical treatment on exercise capacity and muscle force in patients with intrathoracic cancer
Bihiyga Salhi
Charlotte Haenebalcke
S Perez-Bogerd
M Nguyen
Karim Vermaelen
Veerle Surmont
Jan Van Meerbeeck
Eric Derom
C3
Conference
2012
Expressed wishes and incidence of euthanasia in advanced lung cancer patients
Koen Pardon
Reginald Deschepper
Robert Vander Stichele
Jan L Bernheim
Freddy Mortier
Denis Schallier
Paul Germonpre
Daniella Galdermans
Willem Van Kerckhoven
Luc Deliens
et al.
A1
Journal Article
in
EUROPEAN RESPIRATORY JOURNAL
2012
Feasibility of epidermal growth factor receptor mutation testing in cytology samples
Thomas Malfait
Liesbeth Ferdinande
Jan Van Meerbeeck
D Galdermans
Veerle Surmont
Ramses Forsyth
Karim Vermaelen
Marleen Praet
Kurt Tournoy
C3
Conference
2012
Initial analysis of the International Association For the Study of Lung Cancer Mesothelioma database
Valerie W Rusch
Dorothy Giroux
Catherine Kennedy
Enrico Ruffini
Ayten K Cangir
David Rice
Harvey Pass
Hisao Asamura
David Waller
John Edwards
et al.
A1
Journal Article
in
JOURNAL OF THORACIC ONCOLOGY
2012
Mesothelin levels in urine are affected by glomerular leakage and tubular reabsorption
Kevin Hollevoet
Marijn Speeckaert
An-Sofie Decavele
Raymond Vanholder
Jan Van Meerbeeck
Joris Delanghe
A1
Journal Article
in
CLINICAL LUNG CANCER
2012
Phase II clinical trial of first or second-line treatment with bortezomib in patients with malignant pleural mesothelioma
Dean A Fennell
Cliona McDowell
Sara Busacca
Glen Webb
Brian Moulton
Andrew Cakana
Kenneth J O'Byrne
Jan Van Meerbeeck
Paul Donnellan
John McCaffrey
et al.
A1
Journal Article
in
JOURNAL OF THORACIC ONCOLOGY
2012
Radiation-induced oesophagitis in lung cancer patients: is susceptibility for neutropenia a risk factor?
Dirk De Ruysscher
Jan Van Meerbeeck
Katrien Vandecasteele
Cary Oberije
Madelon Pijls
Anne-Marie C Dingemans
Bart Reymen
Angela van Baardwijk
Rinus Wanders
G Lammering
et al.
A1
Journal Article
in
STRAHLENTHERAPIE UND ONKOLOGIE
2012
Response to chemotherapy is predictive in relation to longer overall survival in an individual patient combined-analysis with pleural mesothelioma
Jaine K Blayney
Giovanni L Ceresoli
Bruno Castagneto
Mary ER O'Brien
Baktiar Hasan
Richard Sylvester
Robin Rudd
Jeremy Steele
Sara Busacca
Camillo Porta
et al.
A1
Journal Article
in
EUROPEAN JOURNAL OF CANCER
2012
Serum mesothelin for diagnosing malignant pleural mesothelioma : an individual patient data meta-analysis
Kevin Hollevoet
Johannes B Reitsma
Jenette Creaney
Bogdan D Grigoriu
Bruce W Robinson
Arnaud Scherpereel
Alfonso Cristaudo
Harvey I Pass
Krisitaan Nackaerts
José A Rodriguez Portal
et al.
A1
Journal Article
in
JOURNAL OF CLINICAL ONCOLOGY
2012
The effect of clinical covariates on the diagnostic and prognostic value of soluble mesothelin and megakaryocyte potentiating factor
Kevin Hollevoet
Kristiaan Nackaerts
Olivier Thas
Joël Thimpont
Paul Germonpré
Paul De Vuyst
Lionel Bosquée
Catherine Legrand
Eliane Kellen
Yoshiro Kishi
et al.
A1
Journal Article
in
CHEST
2012
Treatment for non small cell lung cancer, small cell lung cancer and pleural mesothelioma within the EORTC Lung Cancer Group: past, present and future
Mary ER O'Brien
Jan Van Meerbeeck
Veerle Surmont
Corinne Faivre Finn
A2
Journal Article
in
EUROPEAN JOURNAL OF CANCER. SUPPLEMENTS
2012
Treatment of metastatic non-small cell lung cancer: standard of care and future perspectives
Veerle Surmont
Jan Van Meerbeeck
A2
Journal Article
in
MINERVA PNEUMOLOGICA
2012
2011
1st ESMO Consensus conference in lung cancer; Lugano 2010: small-cell lung cancer
R Stahel
N Thatcher
M Früh
C Le Péchoux
PE Postmus
JB Sorensen
E Felip
- Panel members
Jan Van Meerbeeck
A1
Journal Article
in
ANNALS OF ONCOLOGY
2011
A double-blind, randomised, placebo-controlled phase III intergroup study of gefitinib in patients with advanced NSCLC, non-progressing after first line platinum-based chemotherapy (EORTC 08021/ILCP 01/03)
Rabab M Gaafar
Veerle Surmont
Giorgio V Scagliotti
Rob J Van Klaveren
Demetris Papamichael
John J Welch
Baktiar Hasan
Valter Torri
Jan Van Meerbeeck
A1
Journal Article
in
EUROPEAN JOURNAL OF CANCER
2011
Asthma, atopy and COPD in sub-Saharan countries : the challenges
S Musafiri
Guy Joos
Jan Van Meerbeeck
A2
Journal Article
in
EAST AFRICAN JOURNAL OF PUBLIC HEALTH
2011
Carcinoma in situ at the bronchial resection margin: a review
Eric Vallières
Paul Van Houtte
William D Travis
Ramon Rami-Porta
Peter Goldstraw
- International Association for the Study of Lung Cancer (IASLC) International Staging Committee
Jan Van Meerbeeck
A1
Journal Article
in
JOURNAL OF THORACIC ONCOLOGY
2011
Clinical neurological outcome and quality of life among patients with limited small-cell cancer treated with two different doses of prophylactic cranial irradiation in the intergroup phase III trial (PCI99-01, EORTC 22003-08004, RTOG 0212 and IFCT 99-01)
C Le Péchoux
A Laplanche
C Faivre-Finn
T Ciuleanu
R. Wanders
D Lerouge
R Keus
M Hatton
GM Videtic
S Senan
et al.
A1
Journal Article
in
ANNALS OF ONCOLOGY
2011
Development of a multicomponent prediction model for acute esophagitis in lung cancer patients receiving chemoradiotherapy
Kim De Ruyck
Nick Sabbe
Cary Oberije
Katrien Vandecasteele
Olivier Thas
Dirk De Ruysscher
Phillipe Lambin
Jan Van Meerbeeck
Wilfried De Neve
Hubert Thierens
A1
Journal Article
in
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
2011
European guidelines for the management of malignant pleural mesothelioma
ERIC VAN THIEL
Rabab Gaafar
Jan Van Meerbeeck
A2
Journal Article
in
JOURNAL OF ADVANCED RESEARCH
2011
Facts, rumours and speculations about the mesothelioma epidemic
Jan Van Meerbeeck
Ronald Damhuis
Editorial material
2011
Health-related quality of life in non-small-cell lung cancer: an update of a systematic review on methodologic issues in randomized controlled trials
Lily Claassens
Jan Van Meerbeeck
Corneel Coens
Chantal Quinten
Irina Ghislain
Elizabeth K Sloan
Xin Shelley Wang
Galina Velikova
Andrew Bottomley
A1
Journal Article
in
JOURNAL OF CLINICAL ONCOLOGY
2011
Investigational approaches for mesothelioma
Veerle Surmont
Eric RE Van Thiel
Karim Vermaelen
Jan Van Meerbeeck
A2
Journal Article
in
FRONTIERS IN ONCOLOGY
2011
Malignant pleural mesothelioma: the standard of care and challenges for future management
Jan Van Meerbeeck
Arnaud Scherpereel
Veerle Surmont
Paul Baas
A1
Journal Article
in
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
2011
Malignant pleural mesothelioma: when is radiation therapy indicated?
ERE van Thiel
Veerle Surmont
Jan Van Meerbeeck
A1
Journal Article
in
EXPERT REVIEW OF ANTICANCER THERAPY
2011
Metastatic non-small-cell lung cancer: consensus on pathology and molecular tests, first-line, second-line, and third-line therapy: 1st ESMO Consensus Conference in Lung Cancer, Lugano 2010
E Felip
C Gridelli
P Baas
R Rosell
R Stahel
- Panel members
Jan Van Meerbeeck
A1
Journal Article
in
ANNALS OF ONCOLOGY
2011
Minimal important differences for interpreting health-related quality of life scores from the EORTC QLQ-C30 in lung cancer patients participating in randomized controlled trials
John T Maringwa
Chantal Quinten
Madeleine King
Jolie Ringash
David Osoba
Corneel Coens
Francesca Martinelli
Jurgen Vercauteren
Charles S Cleeland
Henning Flechtner
et al.
A1
Journal Article
in
SUPPORTIVE CARE IN CANCER
2011
Prevalence of atopy, asthma and COPD in an urban and a rural area of an African country
Sanctus Musafiri
Jan Van Meerbeeck
Laurent Musango
Guy Brusselle
Guy Joos
Benoit Seminega
Claver Rutayisire
A1
Journal Article
in
RESPIRATORY MEDICINE
2011
Quantitative perfusion scintigraphy or anatomic segment method in lung cancer resection
Tom Holvoet
Jan Van Meerbeeck
Christophe Van De Wiele
Bihiyga Salhi
Eric Derom
A1
Journal Article
in
LUNG CANCER
2011
Raltitrexed in mesothelioma
Veerle Surmont
Jan Van Meerbeeck
A1
Journal Article
in
EXPERT REVIEW OF ANTICANCER THERAPY
2011
Randomised phase II study of amrubicin as single agent or in combination with cisplatin versus cisplatin etoposide as first-line treatment in patients with extensive stage small cell lung cancer: EORTC 08062
Mary ER O'Brien
Krzystof Konopa
Paul Lorigan
Lionel Bosquee
Ernest Marshall
Frederique Bustin
Sabine Margerit
Christian Fink
Jos A Stigt
Anne Marie C Dingemans
et al.
A1
Journal Article
in
EUROPEAN JOURNAL OF CANCER
2011
Recommendations for uniform definitions of surgical techniques for malignant pleural mesothelioma: a consensus report of the International Association for the Study of Lung Cancer International Staging Committee and the International Mesothelioma Interest Group
David Rice
Valerie Rusch
Harvey Pass
Hisao Asamura
Takashi Nakano
John Edwards
Dorothy J Giroux
Seiki Hasegawa
Kemp H Kernstine
David Waller
et al.
A1
Journal Article
in
JOURNAL OF THORACIC ONCOLOGY
2011
Serial measurements of mesothelioma serum biomarkers in asbestos-exposed individuals: a prospective longitudinal cohort study
Kevin Hollevoet
Joris Van Cleemput
Joel Thimpont
Paul De Vuyst
Lionel Bosquee
Kristiaan Nackaerts
Paul Germonpre
Stijn Vansteelandt
Yoshiro Kishi
Joris Delanghe
et al.
A1
Journal Article
in
JOURNAL OF THORACIC ONCOLOGY
2011
Small-cell lung cancer
Jan Van Meerbeeck
Dean A Fennell
Dirk KM De Ruysscher
A1
Journal Article
in
LANCET
2011
Soluble mesothelin, megakaryocyte potentiating factor, and osteopontin as markers of patient response and outcome in mesothelioma
Kevin Hollevoet
Kristiaan Nackaerts
Robert Gosselin
Walter De Wever
Lionel Bosquée
Paul De Vuyst
Paul Germonpré
Eliane Kellen
Catherine Legrand
Yoshiro Kishi
et al.
A1
Journal Article
in
JOURNAL OF THORACIC ONCOLOGY
2011
2010
Adjuvant or neoadjuvant chemotherapy in minimal N2 stage IIIA nonsmall cell lung cancer
SOFIE DE CRAENE
Veerle Surmont
Jan Van Meerbeeck
A1
Journal Article
in
CURRENT OPINION IN ONCOLOGY
2010
Association of TGFβ1 polymorphisms involved in radiation toxicity with TGFβ1 secretion in vitro
Kim De Ruyck
Laurence Beels
Jan Van Meerbeeck
Wilfried De Neve
Hubert Thierens
A1
Journal Article
in
CYTOKINE
2010
Carbonic anhydrase IX expression correlates with FDG uptake by primary non-small cell lung cancer
Gilles Mees
CHRISTEL VANGESTEL
Rudi Dierckx
Patrick Pauwels
Jan Van Meerbeeck
Christophe Van De Wiele
A1
Journal Article
in
CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS
2010
Development, external validation and clinical usefulness of a practical prediction model for radiation-induced dysphagia in lung cancer patients
Cary Dehing-Oberije
Dirk De Ruysscher
Steven Petit
Jan Van Meerbeeck
Katrien Vandecasteele
Wilfried De Neve
Anne Marie C Dingemans
Issam El Naqa
Joseph Deasy
Jeff Bradley
et al.
A1
Journal Article
in
RADIOTHERAPY AND ONCOLOGY
2010
Endobronchial metallic clips to guide high-dose external-beam radiotherapy in radio-occult lung cancer
Thomas Malfait
Marc Van Eijkeren
Jan Van Meerbeeck
Kurt Tournoy
A1
Journal Article
in
EUROPEAN RESPIRATORY JOURNAL
2010
Endurance and resistance training in radically treated respiratory cancer patients: a pilot study
Bihiyga Salhi
Ingel Demets
Ann Simpelaere
Sofie Decraene
Karim Vermaelen
Veerle Surmont
Jan Van Meerbeeck
Eric Derom
A2
Journal Article
in
REHABILITATION RESEARCH AND PRACTICE
2010
EORTC Elderly Task Force and Lung Cancer Group and International Society for Geriatric Oncology (SIOG) experts' opinion for the treatment of non-small-cell lung cancer in an elderly population
AG Pallis
C Gridelli
Jan Van Meerbeeck
L Greillier
U Wedding
D Lacombe
J Welch
CP Belani
M Aapro
A1
Journal Article
in
ANNALS OF ONCOLOGY
2010
Genetic variation in three candidate genes and nicotine dependence, withdrawal and smoking cessation in hospitalized patients
Kim De Ruyck
Kristiaan Nackaerts
Laurence Beels
Joke Werbrouck
Annick De Volder
Marc Meysman
Bihiyga Salhi
Jan Van Meerbeeck
Hubert Thierens
A1
Journal Article
in
PHARMACOGENOMICS
2010
Guidelines of the European Respiratory Society and the European Society of Thoracic Surgeons for the management of malignant pleural mesothelioma
A Scherpereel
P Astoul
P Baas
T Berghmans
H Clayson
P de Vuyst
H Dienenman
F Galateau-Salle
C Hennequin
G Hillerdal
et al.
A1
Journal Article
in
European Respiratory Journal
2010
Inaccurate clinical nodal staging of non-small-cell lung cancer: evidence fro mthe MRC LU22 multicentre randomised trial
N Navani
M Nankivell
RJ Stephens
MKB Parmar
D Gilligan
M Nicolson
HJM Groen
Jan Van Meerbeeck
A1
Journal Article
in
Thorax
2010
Mediastinoscopy vs endosonography for mediastinal nodal staging of lung cancer : a randomized trial
Jouke T Annema
Jan Van Meerbeeck
Robert C Rintoul
Christophe Dooms
Ellen Deschepper
Olaf M Dekkers
Paul De Leyn
Jerry Braun
Nicholas R Carroll
Marleen Praet
et al.
A1
Journal Article
in
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
2010
The emerging role for combined endosonography with fine needle aspiration in lung cancer staging is the scope the right one?
Kurt Tournoy
Jan Van Meerbeeck
Frank Vermassen
A1
Journal Article
in
EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY
2010
The role of EBUS-TBNA for the assessment of hilar lymph nodes
Kurt Tournoy
Jan Van Meerbeeck
A1
Journal Article
in
JOURNAL OF THORACIC ONCOLOGY
2010
Treatment of extensive-stage small cell lung carcinoma: current status and future prospects
Ingel Demedts
Karim Vermaelen
Jan Van Meerbeeck
A1
Journal Article
in
EUROPEAN RESPIRATORY JOURNAL
2010
2009
A pilot phase II clinical trial of the 20S proteasome inhibitor bortezomib in patients with relapsed malignant pleural mesothelioma
DA Fennell
Jan Van Meerbeeck
KJ O'Byrne
P Donnellan
S O'Reilly
R McDermott
L Mutti
G Gaudino
G Webb
S Jackson
et al.
C3
Conference
2009
A prognostic index for progression-free survival in malignant mesothelioma with application to the design of phase II trials: a combined analysis of 10 EORTC trials
J. Francart
E. Vaes
S. Henrard
C. Legrand
P. Baas
R. Gaafar
Jan Van Meerbeeck
R. Sylvester
A. Robert
A1
Journal Article
in
European journal of cancer
2009
Association of TGFβ1 polymorphisms involved in radiation toxicity with TGFβ1 secretion in vitro
Kim De Ruyck
Laurence Beels
Jan Van Meerbeeck
Wilfried De Neve
Hubert Thierens
C3
Conference
2009
Development and external validation of a nomogram for prediction of radiation-induced dysphagia in 493 lung cancer patients treated with chemo-radiotherapy or radiotherapy alone
C Dehing
DOMINIQUE DE RUYSSCHER
S Petit
A Dingemans
Jan Van Meerbeeck
Wilfried De Neve
K Vandecasteele
P Lambin
C3
Conference
2009
Diagnostic performance of soluble mesothelin and megakaryocyte potentiating factor as biomarkers of mesothelioma
Kevin Hollevoet
K Nackaerts
J Thimpont
P Germonpre
P De Vuyst
L Bosquee
C Legrand
K Yoshiro
Joris Delanghe
Jan Van Meerbeeck
C3
Conference
2009
EBUS TBNA for the diagnosis of central parenchymal lung lesions not visible at routine bronchoscopy
Kurt Tournoy
Robert Rintoul
Jan Van Meerbeeck
Nicholas Carroll
Marleen Praet
Robert Buttery
Klaas Van Kralingen
Klaus Rabe
Jouke Annema
A1
Journal Article
in
Lung Cancer
2009
EBUS-TBNA for the Clarification of PET Positive Intra-Thoracic Lymph Nodes-an International Multi-Centre Experience
Robert Rintoul
Kurt Tournoy
Hesham El Daly
Nicholas Carroll
Robert Buttery
Klaas Van Kralingen
Jan Van Meerbeeck
Klaus Rabe
Jouke Annema
A1
Journal Article
in
Journal of Thoracic Oncology
2009
Endoscopic and Endobronchial Ultrasonography According to the Proposed Lymph Node Map Definition in the Seventh Edition of the Tumor, Node, Metastasis Classification for Lung Cancer
Kurt Tournoy
JT Annema
M Krasnik
FJF Herth
Jan Van Meerbeeck
A1
Journal Article
in
JOURNAL OF THORACIC ONCOLOGY
2009
Epidermal growth factor receptor protein expression and gene amplification in Caucasian patients with malignant pleural mesothelioma (MPM)
Veerle Surmont
Marleen Praet
Isabelle Rottiers
ELISABETH BEERENS
BART MATTHYS
Patrick Pauwels
Jan Van Meerbeeck
C3
Conference
2009
Glomerular filtration rate is a confounder for determination of serum soluble mesothelin
Kevin Hollevoet
Dirk Bernard
Frank De Geeter
Natasha Walgraeve
Anja Van den Eeckhaut
Raymond Vanholder
Christophe Van De Wiele
Veronique Stove
Jan Van Meerbeeck
Joris Delanghe
C3
Conference
2009
Glomerular filtration rate is a confounder for the measurement of soluble mesothelin in serum
Kevin Hollevoet
Dirk Bernard
Frank De Geeter
Natasha Walgraeve
Anja Van den Eeckhaut
Raymond Vanholder
Christophe Van De Wiele
Veronique Stove
Jan Van Meerbeeck
Joris Delanghe
A1
Journal Article
in
CLINICAL CHEMISTRY
2009
Is clinical to pathological (c to p) stage migration another Will Rogers phenomenon? An analysis of the IASLC staging database
Jan Van Meerbeeck
K Chansky
P Goldstraw
C3
Conference
2009
Muscle force and mass in patients with respiratory cancer: effects of radical treatment
Bihiyga Salhi
Tom Holvoet
Eric Derom
Jan Van Meerbeeck
C3
Conference
2009
Palliative chemotherapy: do we need yet another end-point?
Jan Van Meerbeeck
P. Baas
Editorial material
2009
Pemetrexed (P) and Cisplatin (C) as either Induction (IC) or Adjuvant (AC) Chemotherapy in stage IB-II Non-Small Cell Lung Cancer (NSCLC): A randomized phase 2 study (EORTC 08051)
Jan Van Meerbeeck
P Germonpre
Frank Vermassen
J Welch
PE Van Schil
C3
Conference
2009
Quantitative Perfusion Scintigraphy (QPS) or the Anatomic Segment Method (ASM) for estimating Postoperative Pulmonary Function (PF) in patients treated for non-small cel lung cancer (NSCLC): a retrospective comparison
Tom Holvoet
Eric Derom
Jan Van Meerbeeck
C3
Conference
2009
Response to chemotherapy predicts longer survival in an individual patient meta-analysis of 1205 patients with mesothelioma
DA Fennell
GL Ceresoli
B Castagneto
P Scullin
M O'Brien
M Parker
B Hasan
R Sylvester
R Rudd
J Steele
et al.
C3
Conference
2009
Soluble mesothelin as a monitoring tool in the management of malignant mesothelioma patients
Kevin Hollevoet
E Kellen
K Nackaerts
L Bosquee
P Germonpre
Joris Delanghe
C Legrand
Jan Van Meerbeeck
C3
Conference
2009
Soluble mesothelin as a tool for early detection of malignant mesothelioma in asbestos-exposed workers
Kevin Hollevoet
J Van Cleemput
J Thimpont
M Vandeweerdt
P De Vuyst
K Nackaerts
Joris Delanghe
C Legrand
Jan Van Meerbeeck
C3
Conference
2009
Stage IIIA-N2 NSCLC: A review of its treatment approaches and future developments
Jan Van Meerbeeck
Veerle Surmont
A1
Journal Article
in
LUNG CANCER
2009
Standard-dose versus higher-dose prophylactic cranial irradiation (PCI) in patients with limited-stage small-cell lung cancer in complete remission after chemotherapy and thoracic radiotherapy (PCI 99-01, EORTC 22003-08004, RTOG 0212 and IFCT 99-01) a randomised clinical trial
Cecile Le Pechoux
Ariane Dunant
Suresh Senan
Aaron Wolfson
Elisabeth Quoix
Corinne Faivre-Finn
Tudor Ciuleanu
Rodrigo Arriagada
Richard Jones
Rinus Wanders
et al.
A1
Journal Article
in
Lancet Oncology
2009
Targeted therapies in the treatment of advanced/metastatic NSCLC
AG Pallis
L Serfass
R Dziadziusko
Jan Van Meerbeeck
D Fennell
D Lacombe
J Welch
C Gridelli
A1
Journal Article
in
EUROPEAN JOURNAL OF CANCER
2009
The IASLC Lung Cancer Staging Project A Proposal for a New International Lymph Node Map in the Forthcoming Seventh Edition of the TNM Classification for Lung Cancer
VW Rusch
H Asamura
H Watanabe
DJ Giroux
R Rami-Porta
P Goldstraw
Jan Van Meerbeeck
A1
Journal Article
in
JOURNAL OF THORACIC ONCOLOGY
2009
The IASLC Lung Cancer Staging Project Data Elements for the Prospective Project
DJ Giroux
R Rami-Porta
K Chansky
JJ Crowley
PA Groome
PE Postmus
V Rusch
JP Sculier
FA Shepherd
L Sobin
et al.
A1
Journal Article
in
JOURNAL OF THORACIC ONCOLOGY
2009
The IASLC Lung Cancer Staging Project Proposals Regarding the Relevance of TNM in the Pathologic Staging of Small Cell Lung Cancer in the Forthcoming (Seventh) Edition of the TNM Classification for Lung Cancer
E Vallieres
FA Shepherd
J Crowley
P Van Houtte
PE Postmus
D Carney
K Chansky
Z Shaikh
P Goldstraw
Jan Van Meerbeeck
A1
Journal Article
in
JOURNAL OF THORACIC ONCOLOGY
2009
The International Association for the Study of Lung Cancer Staging Project Prognostic Factors and Pathologic TNM Stage in Surgically Managed Non-small Cell Lung Cancer
K Chansky
JP Sculier
JJ Crowley
D Giroux
Jan Van Meerbeeck
P Goldstraw
A1
Journal Article
in
JOURNAL OF THORACIC ONCOLOGY
2009
To what degree do patients with advanced lung cancer want to be informed and involved in medical decision-making?: a multicentre study in 13 hospitals in Belgium
K Pardon
Jan Van Meerbeeck
D Schallier
P Germonpre
D Galdermans
W Van Kerckhoven
J Bernheim
R. Deschepper
Freddy Mortier
Robert Vander Stichele
et al.
C3
Conference
2009
Toxicity of EORTC 08031: phase 11 feasibility trial of induction chemotherapy (ICT) followed by extrapleural pneumonectomy (EPP) and postoperative radiotherapy (PORT) for malignant pleural mesothelioma (MPM) cT3N1M0 or less
PE Van Schil
P Baas
R Gaafar
AP Maat
M van de Pol
B Hasan
HM Klomp
AM Abdelrahman
J Welch
Jan Van Meerbeeck
C3
Conference
2009
Trimodality treatment of early stage Malignant Pleural Mesothelioma (MPM): a single institutional experience
Elke Vandenbroucke
Marleen Praet
Karim Vermaelen
Veerle Surmont
Frederic De Ryck
Kurt Tournoy
Robert Gosselin
Wilfried De Neve
Frank Vermassen
Jan Van Meerbeeck
C3
Conference
2009
Validation of soluble mesothelin: design and preliminary results of a Belgian multicentric observational study
Kevin Hollevoet
E Kellen
K Nackaerts
J Thimpont
P Germonpre
P De Vuyst
L Bosquee
Joris Delanghe
C Legrand
Jan Van Meerbeeck
C3
Conference
2009
What is the role for surgery in patients with stage III non-small cell lung cancer ?
Elke Vandenbroucke
Frederic De Ryck
Veerle Surmont
Jan Van Meerbeeck
A1
Journal Article
in
Current Opinion in Pulmonary Medicine
2009
2008
A guide to staging in lung cancer, but potentially misleading without attention to the details
Kurt Tournoy
GEORGES VAN MAELE
Jan Van Meerbeeck
A1
Journal Article
in
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
2008
Advances in the systemic therapy of malignant pleural mesothelioma
DA FENNELL
G GAUDINO
KJ O'BYRNE
L MUTTI
Jan Van Meerbeeck
A1
Journal Article
in
NATURE CLINICAL PRACTICE ONCOLOGY
2008
Behandeling van het maligne pleuramesothelioom.
R DE PAUW
L VANWALLEGHEM
Frank Vermassen
SABINE MEERSSCHOUT
Marleen Praet
Wilfried De Neve
Guy Joos
Jan Van Meerbeeck
A2
Journal Article
in
TIJDSCHRIFT VOOR GENEESKUNDE
2008
Chemotherapy in addition to supportive care improves survival in advanced non-small-cell lung cancer: A systematic review and meta-analysis of individual patient data from 16 randomized controlled trials - NSCLC meta-analyses collaborative group
S BURDETT
R STEPHENS
L STEWART
J TIERNEY
A AUPERIN
T LE CHEVALIER
C LE PECHOUX
JP PIGNON
R ARRIAGADA
J HIGGINS
et al.
A1
Journal Article
in
JOURNAL OF CLINICAL ONCOLOGY
2008
De rol van adjuvante chemotherapie bij volledig gereseceerde niet-kleincellige longkanker.
Elke Van Schoote
Frank Vermassen
Guy Joos
Jan Van Meerbeeck
A2
Journal Article
in
TIJDSCHRIFT VOOR GENEESKUNDE
2008
Development, external validation and further improvement of a prediction model for survival of non-small cell lung cancer patients treated with (Chemo)radiotherapy
S Yu
C Dehing-Oberije
D De Ruysscher
K Van Beek
Y Lievens
Jan Van Meerbeeck
Wilfried De Neve
G Fung
B Rao
P Lambin
C3
Conference
2008
FDG uptake by the bone marrow in NSCLC patients is related to TGF-beta but not to VEGF or G-CSF serum levels
Christophe Van De Wiele
F VANDEVYVER
C DEBRUYNE
Jan Philippé
Jan Van Meerbeeck
A1
Journal Article
in
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
2008
Irinotecan and cisplatin with concurrent thoracic radiotherapy in a once-every-three-weeks schedule in patients with limited-disease small-cell lung cancer: A phase I study
WX DE JONG
MJA DE JONGE
AHD VAN DER LEEST
Jan Van Meerbeeck
HJM GROEN
A1
Journal Article
in
LUNG CANCER
2008
Modern radiotherapy as part of combined modality treatment in locally advanced non-small cell lung cancer: Present status and future prospects
Jan Van Meerbeeck
SABINE MEERSSCHOUT
R DE PAUW
Indira Madani
Wilfried De Neve
A1
Journal Article
in
ONCOLOGIST
2008
Single-agent pemetrexed for chemonaive and pretreated patients with malignant pleural mesothelioma - Results of an International Expanded Access Program
P TAYLOR
B CASTAGNETO
G DARK
M MARANGOLO
GV SCAGLIOTTI
RJ VAN KLAVEREN
R LABIANCA
M SERKE
W SCHUETTE
Jan Van Meerbeeck
et al.
A1
Journal Article
in
JOURNAL OF THORACIC ONCOLOGY
2008
The controversial role of surgery in stage III NSCLC
Jan Van Meerbeeck
Editorial material
2008
The impact of additional prognostic factors on survival and their relationship with the anatomical extent of disease expressed by the 6th edition of the TNM classification of malignant tumors and the proposals for the 7th edition
JP SCULIER
K CHANSKY
JJ CROWLEY
Jan Van Meerbeeck
P GOLDSTRAW
A1
Journal Article
in
JOURNAL OF THORACIC ONCOLOGY
2008
The sound of the parasite. diagnosing mediastinal cysts with endoscopic ultrasound techniques
Kurt Tournoy
B ROMBAUT
H GOEMINNE
Marleen Praet
Frank Vermassen
Robert Gosselin
Jan Van Meerbeeck
Editorial material
2008
The yield of endoscopic ultrasound in lung cancer staging: Does lymph node size matter?
Kurt Tournoy
Frederic De Ryck
LIEVE VANWALLEGHEM
Marleen Praet
Frank Vermassen
GEORGES VAN MAELE
Jan Van Meerbeeck
A1
Journal Article
in
JOURNAL OF THORACIC ONCOLOGY
2008
Transesophageal endoscopic ultrasound with fine needle aspiration in the preoperative staging of malignant pleural mesothelioma
Kurt Tournoy
Sjaak A Burgers
Jouke T Annema
Frank Vermassen
Marleen Praet
Marianne Smits
Houke M Klomp
Jan Van Meerbeeck
Paul Baas
A1
Journal Article
in
CLINICAL CANCER RESEARCH
2008
What is the optimal treatment of stage IIIA-N2 non-small-cell lung cancer after EORTC?
Jan Van Meerbeeck
Rebecca De Pauw
Kurt Tournoy
A1
Journal Article
in
EXPERT REVIEW OF ANTICANCER THERAPY
2008
2007
Evidence-based supportive management in lung cancer
Jan Van Meerbeeck
C3
Conference
2007
Integrated FDG-PET/CT does not make invasive staging of the intrathoracic lymph nodes in non-small cell lung cancer redundant : a prospective study
Kurt Tournoy
S. Maddens
Robert Gosselin
GEORGES VAN MAELE
Jan Van Meerbeeck
A. Kelles
A1
Journal Article
in
THORAX
2007
Lessons to learn from EORTC study 08981: A feasibility study of induction chemoradiotherapy followed by surgical resection for stage IIIB non-small cell lung cancer
V SURMONT
RJ VAN KLAVEREN
C GOOR
F SCHRAMEL
C MANEGOLD
C LEGRAND
P VAN SCHIL
Jan Van Meerbeeck
A1
Journal Article
in
LUNG CANCER
2007
Neoadjuvant chemotherapy in early stage non-small cell lung cancer
Jan Van Meerbeeck
R DE PAUW
A1
Journal Article
in
EJC SUPPLEMENTS
2007
Neoadjuvant chemotherapy in the treatment of nonsmall-cell lung cancer
R DE PAUW
Jan Van Meerbeeck
A1
Journal Article
in
CURRENT OPINION IN ONCOLOGY
2007
Polymorphisms in base-excision repair and nucleotide-excision repair genes in relation to lung cancer risk
Kim De Ruyck
Marcin Szaumkessel
Isabelle De Rudder
ANNELORE DEHOORNE
Anne Vral
Kathleen Claes
Anja Velghe
Jan Van Meerbeeck
Hubert Thierens
A1
Journal Article
in
MUTATION RESEARCH-GENETIC TOXICOLOGY AND ENVIRONMENTAL MUTAGENESIS
2007
Predicting risk of radiation-induced lung injury
Indira Madani
Kim De Ruyck
H GOEMINNE
Wilfried De Neve
Hubert Thierens
Jan Van Meerbeeck
A1
Journal Article
in
JOURNAL OF THORACIC ONCOLOGY
2007
Preoperative chemotherapy in patients with resectable non-small cell lung cancer: results of the MRC LU22/NVALT 2/EORTC 08012 multicentre randomised trial and update of systematic review
D GILLIGAN
M NICOLSON
I SMITH
H GROEN
O DALESIO
P GOLDSTRAW
M HATTON
P HOPWOOD
C MANEGOLD
F SCHRAMEL
et al.
A1
Journal Article
in
LANCET
2007
Randomized controlled trial of resection versus radiotherapy after induction chemotherapy in stage IIIA-N2 non-small-cell lung cancer
Jan Van Meerbeeck
GWPM KRAMER
PEY VAN SCHIL
C LEGRAND
EF SMIT
F SCHRAMEL
VC TJAN-HEIJNEN
B BIESMA
C DEBRUYNE
N VAN ZANDWIJK
et al.
A1
Journal Article
in
JOURNAL OF THE NATIONAL CANCER INSTITUTE
2007
Re: Randomized controlled trial of resection versus radiotherapy after induction chemotherapy in stage IIIA-N2 non-small-cell lung cancer - Response
P. Van Schil
Jan Van Meerbeeck
A1
Journal Article
in
JOURNAL OF THE NATIONAL CANCER INSTITUTE
2007
Reply: Randomized controlled trial of resection versus radiotherapy after induction chemotherapy in stage IIIA-N2 non-small cell lung cancer
Jan Van Meerbeeck
PEY VAN SCHIL
S SENAN
A1
Journal Article
in
JOURNAL OF THORACIC ONCOLOGY
2007
Symptoms and patient-reported well-being: Do they predict survival in malignant pleural mesothelioma? A prognostic factor analysis of EORTC-NCIC 08983: Randomized phase III study of cisplatin with or without raltitrexed in patients with malignant pleural mesothelioma
A BOTTOMLEY
C COENS
F EFFICACE
R GAAFAR
C MANEGOLD
S BURGERS
M VINCENT
C LEGRAND
Jan Van Meerbeeck
A1
Journal Article
in
JOURNAL OF CLINICAL ONCOLOGY
2007
Transoesophageal endoscopic ultrasound with fine needle aspiration (EUS-FNA) in lung cancer staging: does lymph node size matter?
Kurt Tournoy
Frank Vermassen
LIEVE VANWALLEGHEM
Frank De Rijck
Marleen Praet
GEORGES VAN MAELE
Jan Van Meerbeeck
C3
Conference
2007
2006
A case of recurrent non-small-cell lung carcinoma and paraneoplastic Cushing's syndrome
I. Noorlander
J. W. Elte
O. C. Manintveld
Kurt Tournoy
Marleen Praet
Jan Van Meerbeeck
J. G. Aerts
A1
Journal Article
in
LUNG CANCER
2006
A phase II study of induction therapy with carboplatin and gemcitabine among patients with locally advanced non-small cell lung cancer
JGJV AERTS
V SURMONT
RJ VAN KLAVEREN
KY TAN
S SENAN
G VAN WIJHE
R VERNHOUT
GT VERHOEVEN
HC HOOGSTEDEN
Jan Van Meerbeeck
A1
Journal Article
in
JOURNAL OF THORACIC ONCOLOGY
2006
Chemotherapy in malignant mesothelioma: What's up, doc?
Jan Van Meerbeeck
Editorial material
2006
Combination chemotherapy: Moving beyond pemetrexed
Jan Van Meerbeeck
C3
Conference
2006
Concurrent chemotherapy (carboplatin, paclitaxel, etoposide) and involved-field radiotherapy in limited stage small cell lung cancer: a Dutch multicenter phase II study
P BAAS
JSA BELDERBOS
S SENAN
HB KWA
A VAN BOCHOVE
H VAN TINTEREN
JA BURGERS
Jan Van Meerbeeck
A1
Journal Article
in
BRITISH JOURNAL OF CANCER
2006
Docetaxel and cisplatin as induction chemotherapy in patients with pathologically-proven stage IIIA N2 non-small cell lung cancer: a phase II study of the European organization for research and treatment of cancer (EORTC 08984)
B BIESMA
C MANEGOLD
HJM SMIT
L WILLEMS
C LEGRAND
A PASSIOUKOV
Jan Van Meerbeeck
G GIACCONE
A1
Journal Article
in
EUROPEAN JOURNAL OF CANCER
2006
Does downstaging in patients (pts) with IIIA-N2 non-small cell lung cancer (NSCLC) and a response to induction chemotherapy (ICT) influence outcome with surgery (S) or radiotherapy (RT)? An exploratory analysis of EORTC 08941
Jan Van Meerbeeck
GW KRAMER
C LEGRAND
EF SMIT
A PASSIOUKOV
G GIACCONE
N VAN ZANDWIJK
PE VAN SCHIL
C3
Conference
2006
Extrapleural pleuropneumonectomy in selected patients with epitheloid or biphasic pleural mesothelioma
LIEVE VANWALLEGHEM
Hannelore Goeminne
Jan Van Meerbeeck
Frank Vermassen
Robert Gosselin
Marleen Praet
C3
Conference
2006
Is a patient's self-reported health-related quality of life a prognostic factor for survival in non-small-cell lung cancer patients? A multivariate analysis of prognostic factors of EORTC study 08975
F EFFICACE
A BOTTOMLEY
EF SMIT
P LIANES
C LEGRAND
C DEBRUYNE
F SCHRAMEL
HJ SMIT
R GAAFAR
B BIESMA
et al.
A1
Journal Article
in
ANNALS OF ONCOLOGY
2006
Pemetrexed in thoracic cancer
H GOEMINNE
Jan Van Meerbeeck
A1
Journal Article
in
EXPERT OPINION ON PHARMACOTHERAPY
2006
Progression-free survival rate as primary end point for phase II cancer clinical trials: Application to mesothelioma - The EORTC Lung Cancer Group
J FRANCART
C LEGRAND
R SYLVESTER
M VAN GLABBEKE
Jan Van Meerbeeck
A ROBERT
A1
Journal Article
in
JOURNAL OF CLINICAL ONCOLOGY
2006
Quality assurance of thoracic radiotherapy in EORTC 08941: A randomised trial of surgery versus thoracic radiotherapy in patients with stage IIIA non-small-cell lung cancer (NSCLC) after response to induction chemotherapy
GWPM KRAMER
CL LEGRAND
P VAN SCHIL
L UITTERHOEVE
EF SMIT
F SCHRAMEL
B BIESMA
V TJAN-HEIJNEN
N VAN ZANDWIJK
T SPLINTER
et al.
A1
Journal Article
in
EUROPEAN JOURNAL OF CANCER
2006
Raltitrexed and pemetrexed studies in mesothelioma have not shown improved quality of life nor prolonged survival compared with effective pleurodesis with thoracoscopic talc poudrage - Reply
Jan Van Meerbeeck
A BOTTOMLEY
A1
Journal Article
in
JOURNAL OF CLINICAL ONCOLOGY
2006
Re-188-HDD/lipiodol therapy for hepatocellular carcinoma: an activity escalation study
Bieke Lambert
Klaus Bacher
Luc Defreyne
Hans Van Vlierberghe
Jae Min Jeong
Rong Fu Wang
Jan Van Meerbeeck
Peter Smeets
Roberto Troisi
Hubert Thierens
et al.
A1
Journal Article
in
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
2006
Short-term treatment-related symptoms and quality of life: Results from an international randomized phase III study of cisplatin with or without raltitrexed in patients with malignant pleural mesothelioma: An EORTC Lung-Cancer Group and National Cancer Institute, Canada, Intergroup Study
A BOTTOMLEY
R GAAFA
C MANEGOLD
S BURGERS
C COENS
C LEGRAND
M VINCENT
G GIACCONE
Jan Van Meerbeeck
A1
Journal Article
in
JOURNAL OF CLINICAL ONCOLOGY
2006
Systemic therapy of bronchioloalveolar carcinoma: Results of the first IASLC/ASCO consensus conference on bronchioloalveolar carcinoma
MG KRIS
G GIACCONE
A DAVIES
M FUKUOKA
DH GARFIELD
J JASSEM
EA QUOIX
AB SANDLER
GV SCAGLIOTTI
Jan Van Meerbeeck
et al.
A1
Journal Article
in
JOURNAL OF THORACIC ONCOLOGY
2006
The high post-test probability of a cytological examination renders further investigations to establish a diagnosis of epithelial malignant pleural mesothelioma redundant
JGJV Aerts
M Delahaye
TH van der Kwast
B Davidson
HC Hoogsteden
Jan Van Meerbeeck
A1
Journal Article
in
DIAGNOSTIC CYTOPATHOLOGY
2006
Treatment compliance and early toxicity of 3D involved-field radiotherapy (RT) and chemotherapy (CT) in a randomized study comparing induction CT followed by concurrent CT-RT with concurrent CT-RT followed by consolidation CT, in non-small-cell lung cancer (NSCLC)
S SENAN
Jan Van Meerbeeck
F CARDENAL
J VAN STEENKISTE
J STIGT
F AKYOL
J BAKKER
J DUPONT
W DE GERSEM
U RICARDI
C3
Conference
2006
2005
Consensus report: Pretreatment minimal staging and treatment of potentially resectable malignant pleural mesothelioma
Jan Van Meerbeeck
M BOYER
A1
Journal Article
in
LUNG CANCER
2005
Economic evaluation of three two-drug chemotherapy regimens in advanced non-small-cell lung cancer
N NEYMARK
P LIANES
EF SMIT
Jan Van Meerbeeck
A1
Journal Article
in
PHARMACOECONOMICS
2005
Efficacy of gemcitabine plus platinum chemotherapy compared with other platinum containing regimens in advanced non-small-cell lung cancer: a meta-analysis of survival outcomes
T LE CHEVALIER
G SCAGLIOTTI
R NATALE
S DANSON
R ROSELL
R STAHEL
P THOMAS
RM RUDD
J VANSTEENKISTE
N THATCHER
et al.
A1
Journal Article
in
LUNG CANCER
2005
Esophageal endoscopic ultrasound with fine-needle aspiration with an on-site cytopathologist - High accuracy for the diagnosis of mediastinal lymphadenopathy
Kurt Tournoy
Marleen Praet
GEORGES VAN MAELE
Jan Van Meerbeeck
A1
Journal Article
in
CHEST
2005
Improving the specificity of fluorescence bronchoscopy for the analysis of neoptastic lesions of the bronchial tree by combination with optical spectroscopy: preliminary communication
MPL BARD
A AMELINK
M SKURICHINA
M DEN BAKKER
SA BURGERS
Jan Van Meerbeeck
RPW DUIN
JGJV AERTS
HC HOOGSTEDEN
HJCM STERENBORG
A1
Journal Article
in
LUNG CANCER
2005
Morbidity and mortality in the surgery arm of EORTC 08941 trial
P VAN SCHIL
Jan Van Meerbeeck
G KRAMER
T SPLINTER
C LEGRAND
G GIACCONE
C MANEGOLD
N VAN ZANDWIJK
A1
Journal Article
in
EUROPEAN RESPIRATORY JOURNAL
2005
Randomized phase III study of cisplatin with or without raltitrexed in patients with malignant pleural mesothelioma: An intergroup study of the European Organisation for Research and Treatment of Cancer Lung Cancer Group and the National Cancer Institute of Canada
Jan Van Meerbeeck
R GAAFAR
C MANEGOLD
RJ VAN KLAVEREN
EA VAN MARCK
M VINCENT
C LEGRAND
A BOTTOMLEY
C DEBRUYNE
G GIACCONE
A1
Journal Article
in
JOURNAL OF CLINICAL ONCOLOGY
2005
Richtlijn 'Niet-kleincellig longcarcinoom; stadiëring behandeling'
Jan Van Meerbeeck
CCE Koning
VCG Tjan-Heijnen
AG Boekema
CJE Kaandorp
JS Burgers
A2
Journal Article
in
NEDERLANDSCH TIJDSCHRIFT VOOR GENEESKUNDE
2005
Willingness of pulmonologists to guide COPD patients in smoking cessation
C BOLMAN
C SINO
P HEKKING
A VAN KEIMPEMA
Jan Van Meerbeeck
A1
Journal Article
in
PATIENT EDUCATION AND COUNSELING
2005
2004
An open letter to all members of the IASLC
F MACBETH
R STEPHENS
RP ABRATT
R ARRIAGADA
D BATT
A BEZJAK
L BILLINGHAM
J CROWLEY
M O'BRIEN
T SHAKESPEARE
et al.
A1
Journal Article
in
LUNG CANCER
2004
Cisplatin-based adjuvant chemotherapy in patients with completely resected non-small-cell lung cancer
M KOZLOWSKI
J LAUDANSK
T GRODZK I
M CHABOWSKI
A PLUZANSKA
L GASPAR
T CIULEANU
J BAUMOHL
M CERNA
M BITENC
et al.
A1
Journal Article
in
NEW ENGLAND JOURNAL OF MEDICINE
2004
Fatal outcome of a hypersensitivity reaction to paclitaxel: a critical review of premedication regimens
JS KLOOVER
MA DEN BAKKER
H GELDERBLOM
Jan Van Meerbeeck
A1
Journal Article
in
BRITISH JOURNAL OF CANCER
2004
Hypofractionated external beam radiotherapy as retreatment for symptomatic non-small-cell lung carcinoma: An effective treatment?
GWPM KRAMER
S GANS
E ULLMANN
Jan Van Meerbeeck
CC LEGRAND
JWH LEER
A1
Journal Article
in
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
2004
Inadequacy of the RECIST criteria for response evaluation in patients with malignant pleural mesothelioma
RJ VAN KLAVEREN
JGJV AERTS
H DE BRUIN
G GIACCONE
C MANEGOLD
Jan Van Meerbeeck
A1
Journal Article
in
LUNG CANCER
2004
Proteomic analysis of exosomes isolated from human malignant pleural effusions
MP BARD
JP HEGMANS
A HEMMES
TM LUIDER
R WILLEMSEN
LAA SEVERIJNEN
Jan Van Meerbeeck
SA BURGERS
HC HOOGSTEDEN
Bart Lambrecht
A1
Journal Article
in
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY
2004
Raman microspectroscopic mapping studies of human bronchial tissue
S KOLJENOVIC
TCB SCHUT
Jan Van Meerbeeck
APWM MAAT
SA BURGERS
PE ZONDERVAN
JM KROS
GJ PUPPELS
A1
Journal Article
in
JOURNAL OF BIOMEDICAL OPTICS
2004
Screening and diagnosis of NSCLC
Jan Van Meerbeeck
Kurt Tournoy
A1
Journal Article
in
ANNALS OF ONCOLOGY
2004
2003
Three-arm randomized study of two cisplatin-based regimens and paclitaxel plus gemcitabine in advanced non-small-cell lung cancer: A phase III trial of the European Organization for Research and Treatment of Cancer Lung Cancer Group - EORTC 08975
E. F. Smit
Jan Van Meerbeeck
P. Lianes
C. Debruyne
C. Legrand
F. Schramel
H. Smit
R. Gaafar
B. Biesma
C. Manegold
et al.
A1
Journal Article
in
JOURNAL OF CLINICAL ONCOLOGY
2003
Validation of the Charlson comorbidity index in patients with operated primary non-small cell lung cancer
O BIRIM
APWM MAAT
AP KAPPETEIN
Jan Van Meerbeeck
RAM DAMHUIS
AMC BOGERS
A1
Journal Article
in
EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY
2003
1999
A randomized study comparing vincristine, adriamycin, cyclophosphamide (VAC) to carboplatin, etoposide (CE) in previously untreated small cell lung cancer (SCLC).
Guy Joos
Philippe Pinson
D Van Renterghem
Jan Van Meerbeeck
J Boie
D Galdermans
W Van Roelen
C3
Conference
1999
1996
Second primary lung cancer in Flanders : frequency, clinical presentation, treatment and prognosis
Jan Van Meerbeeck
J Weyler
A Thibaut
J Vansteenkist
A Aumann
G Deneffe
D Galdermans
M Haelterman
Guy Joos
M Noppen
et al.
A1
Journal Article
in
LUNG CANCER
1996